Xtx Topco LTD Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Xtx Topco LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $318,494 - $447,568	-3,222 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $7,630 - $12,182	116 Added 3.73%	3,222 $313,000
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $199,001 - $284,975	3,106 New	3,106 $212,000

565K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.49B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.